Connection

Laurent Peyrin-Biroulet to Opportunistic Infections

Back to Details
This is a "connection" page, showing publications Laurent Peyrin-Biroulet has written about Opportunistic Infections.
Laurent Peyrin-Biroulet
Connection Strength
0.054
Opportunistic Infections
  1. Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis. Aliment Pharmacol Ther. 2018 01; 47(2):219-228.
    View in: PubMed
    Score: 0.027
  2. Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease. Clin Pharmacol Ther. 2017 Oct; 102(4):633-641.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.